This content is machine translated Lifestyle interventions Risk factors for non-compliance Diet is one of the most influential risk factors for metabolic, cardiovascular and several other disease groups. Optimizing nutrition is therefore of enormous importance in prevention and therapy. For the… CME-Test
View Post 10 min This content is machine translated Obesity Possibilities of nutritional therapy The prevalence of people with overweight and obesity in Europe is almost 60%, and the World Health Organization (WHO) estimates that obesity is (partly) responsible for around 1.2 million deaths… CME-Test
View Post 6 min This content is machine translated "Antimicrobial stewardship" Recognize local wound infection and risk of systemic spread A local infection is one of the most common causes of delayed wound healing. The TILI score can be used to assess whether a local wound infection is present and…
View Post 4 min This content is machine translated Acute myocardial infarction and heart failure in young diabetics Type 2 with a poor risk profile for CVD Type 1 and type 2 diabetes differ in many ways, but both types are strongly associated with a high risk of cardiovascular complications. T2D at a young age is considered…
View Post 6 min This content is machine translated Incretin-based therapies for type 2 diabetes Evolution of therapy options continues Incretin mimetics are an attractive treatment option, particularly for the subgroup of overweight type 2 diabetics, as they not only have glucose-lowering effects, but have also demonstrated clinical benefits in…
View Post 4 min This content is machine translated Pharmacotherapy for people over 80 A case of age discrimination? SGLT2 inhibitors and GLP1 receptor agonists have emerged as the drugs of first choice in the guidelines for type 2 diabetes. Sulfonylureas and insulin, on the other hand, were deprioritized…
View Post 5 min This content is machine translated Heart failure and type 2 diabetes SGLT-2-i now recommended for the entire LVEF spectrum Based on data from large clinical trials, it is currently recommended that all patients with diabetes and chronic heart failure – regardless of left ventricular ejection fraction – are treated…
View Post 5 min This content is machine translated Diabetic neuropathy and retinopathy How risky are SGLT2i and GLP1-RA? Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP1-RA) play an important role in diabetes therapy. However, their effect on diabetic neuropathy and retinopathy is not clear.…
View Post 5 min This content is machine translated Chronic wounds State-of-the-art wound management: pioneering innovations Personalized medicine and technological innovations are among the most important current trends in wound diagnostics and treatment. In the field of stage-appropriate wound care, tissue engineering and smart dressings, for…
View Post 4 min This content is machine translated SGLT2i for heart failure HF prevalence in diabetes patients is underestimated in everyday clinical practice SGLT2 inhibitors can significantly reduce the risk of hospitalization for heart failure (HF) and death from cardiovascular causes in patients with diabetes and HF. However, the diagnosis of HF is…
View Post 6 min This content is machine translated Cold plasma for chronic wounds Impressive evidence base of effects that promote wound healing Numerous clinical studies have shown that cold atmospheric pressure plasma has great potential for treating poorly healing and chronic wounds. It is an innovative method to accelerate wound healing. In…
